3 New Patient Organizations Join the CATALIS Network
We are pleased to announce that three new organizations have joined the CATALIS Network: The Canadian Association of Paroxysmal Nocturnal Haemoglobinuria (PNH) Patients, Crohn’s and Colitis Canada, and Pulmonary Hypertension Association Canada (PHA). These new members join the more than thirty patient-partner organizations currently involved in our Network.
The CATALIS Network is committed to optimizing clinical research in Quebec to accelerate the development of innovative patient care for everyone’s benefit. Integrating these new organizations will increase our ability to represent patients’ voices and cover a wider range of medical conditions, expertise, and experiences in the service of clinical research.
“The Canadian PNH Association is thrilled to announce its partnership with CATALIS. We strongly believe that it is essential for PNH patients to have access to a range of therapeutic options. By partnering with CATALIS, we aim to facilitate access to innovative clinical trials and support research in Quebec. Research in PNH is evolving rapidly and promising new treatment options are emerging. This partnership will allow us to expand options for patients and support them in their search for alternative therapeutic solutions. We look forward to working together to bring a variety of treatment options to PNH patients and improve their quality of life. ” – Barry Katsof, Founder and President, Canadian Association of PNH Patients
“Inflammatory bowel disease (IBD) presents significant challenges that require innovative solutions to improve patient outcomes. At Crohn’s and Colitis Canada, we are committed to leading the way in developing new approaches to treatment and care. That’s why we are proud to partner with CATALIS in its mission to optimize the clinical research environment and accelerate the development of innovative care for the benefit of people living with IBD in Quebec and beyond.”– Kate Lee, Vice President, Research & Patient Programs, Crohn’s and Colitis Canada
“PHA Canada is thrilled to collaborate with CATALIS Quebec in a partnership that aligns perfectly with our mission to enhance access to cutting-edge clinical research for those affected by pulmonary hypertension in Quebec. By working together, we are not only opening doors to new therapeutic possibilities but also empowering patients and their families to make informed decisions about their care. We are proud to join forces with CATALIS, a leader in clinical research, to bring hope and innovation to our community.”– Jamie Myrah, Executive Director, PHA Canada
Share:
